ANIP Stock Summary and Trading Ideas (Ani Pharmaceuticals | NASDAQ:ANIP)

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

What symbol and exchange does Ani Pharmaceuticals shares trade?

Ani Pharmaceuticals trades on the NASDAQ stock market under the symbol ANIP.

What is Ani Pharmaceuticals stock price doing today?

As of June 5, 2026, ANIP stock price climbed to $81.11 with 329,844 million shares trading.

What is Ani Pharmaceuticals's Beta?

ANIP has a beta of 1.12, meaning it tends to be more sensitive to market movements. ANIP has a correlation of 0.14 to the broad based SPY ETF.

How much is Ani Pharmaceuticals worth?

ANIP has a market cap of $1.84 billion. This is considered a Small Cap stock.

How much money does Ani Pharmaceuticals make?

Last quarter Ani Pharmaceuticals reported $237 million in Revenue and $2.05 earnings per share. This beat revenue expectation by $30 million and exceeded earnings estimates by $.82.

What is the highest and lowest price Ani Pharmaceuticals traded in the last 3 year period?

In the last 3 years, ANIP traded as high as $99.50 and as low as $48.20.

What are the top ETFs holding Ani Pharmaceuticals?

The top ETF exchange traded funds that ANIP belongs to (by Net Assets): IJR, VTI, IWM, AVUV, VXF.

Is Ani Pharmaceuticals (ANIP) a good investment?

ANIP has outperformed the market in the last year with a return of +35.5%, while the SPY ETF gained +25.6%. However, in the most recent history, ANIP shares have underperformed the stock market with its stock returning +7.3% in the last 3 month period and -1.9% for the last 2 week period, while SPY has returned +8.5% and -1.1%, respectively.

What are the support and resistance levels for Ani Pharmaceuticals (ANIP)?

ANIP support price is $77.27 and resistance is $81.13 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ANIP shares will trade within this expected range on the day.